Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07191067 · ClinicalTrials.gov registry record · NA
Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty
A NA study of Pain, sponsored by Synaptrix.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 4
- Study locations
NCT07191067: Recruiting NA study of Pain, sponsored by Synaptrix.
NCT07191067 is a NA study of Pain that is actively recruiting participants, run by Synaptrix. The registered enrollment target is 120 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (61% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07191067, a NA study of Pain, is actively recruiting participants, sponsored by Synaptrix.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 4
- Study locations
Study Summary
Multi-center, randomized, blinded, sham-controlled study to determin the safety and efficacy of the NOVABLOC system on post-operative pain in patients undergoing TKA procedures.
Primary Outcome
The worst pain felt by each subject at day 10 after the TKA procedure (as measured by question 3 on the BPI)
Conditions Studied
Interventions
- DEVICE Percutaneous radiofrequency electrical nerve stimulation
- DEVICE Non-therapeutic stimulation
Study Locations (4)
Alabama
- Alabama Orthopedic Sports Medicine & Baldwin County Surgery Center - Daphne
California
- Premier Orthopaedic and Trauma Specialists - Upland
North Carolina
- University of North Carolina - Chapel Hill
Washington
- Virginia Mason Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-09-30 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
What NCT07191067 shows while recruiting
NCT07191067 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Percutaneous radiofrequency electrical nerve stimulation is the first listed.
NCT07191067 reports a single indexed study location in Alabama, California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT07191067 about?
NCT07191067 is a clinical study titled "Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty". Multi-center, randomized, blinded, sham-controlled study to determin the safety and efficacy of the NOVABLOC system on post-operative pain in patients undergoing TKA procedures.
What is the current status of trial NCT07191067?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-09-30. Estimated completion is 2026-03-30.
What conditions does trial NCT07191067 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT07191067?
The interventions under investigation include: Percutaneous radiofrequency electrical nerve stimulation (DEVICE), Non-therapeutic stimulation (DEVICE).
Who is sponsoring clinical trial NCT07191067?
This trial is sponsored by Synaptrix, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07191067 being conducted?
This trial has 4 study locations across Alabama, California, North Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07191067's enrollment target sits among peer trials
120 135th of 374 higher than 229 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI